| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 74.9% | 76.4% | ▲ +1.4% |
| Healthcare Services | 24.5% | 23.1% | ▼ -1.4% |
| Healthcare Equipment & Supplies | 0.5% | 0.5% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.4% | 77.8% | ▲ +1.4% |
| Healthcare Services | 23.1% | 21.7% | ▼ -1.4% |
| Healthcare Equipment & Supplies | 0.5% | 0.5% | ● 0.0% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | Rubicon Research Limited ₹6.56 L |
Pharmaceuticals & Biotechnology | 0.43% |
| # | Stock | Sector | Last Weight (Aug 2026) |
|---|---|---|---|
| 1 | Jubilant Pharmova Limited ₹7.59 L |
Pharmaceuticals & Biotechnology | 0.50% |
| 2 | Eris Lifesciences Limited ₹7.48 L |
Pharmaceuticals & Biotechnology | 0.50% |
| 3 | Pfizer Limited ₹7.59 L |
Pharmaceuticals & Biotechnology | 0.50% |
| 4 | Indegene Limited ₹6.76 L |
Healthcare Services | 0.45% |
| 5 | Blue Jet Healthcare Ltd ₹3.15 L |
Pharmaceuticals & Biotechnology | 0.21% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Dr. Reddy's Laboratories Limited ₹85.68 L |
Pharmaceuticals & Biotechnology | 4.99% | 5.58% | +0.59% |
| 2 | Laurus Labs Limited ₹87.85 L |
Pharmaceuticals & Biotechnology | 5.28% | 5.72% | +0.44% |
| 3 | Sun Pharmaceutical Industries Limited ₹1.56 Cr |
Pharmaceuticals & Biotechnology | 9.90% | 10.13% | +0.23% |
| 4 | Divi's Laboratories Limited ₹1.35 Cr |
Pharmaceuticals & Biotechnology | 8.53% | 8.76% | +0.23% |
| 5 | Wockhardt Limited ₹19.91 L |
Pharmaceuticals & Biotechnology | 1.10% | 1.30% | +0.20% |
| 6 | Mankind Pharma Limited ₹32.32 L |
Pharmaceuticals & Biotechnology | 1.94% | 2.10% | +0.16% |
| 7 | Emcure Pharmaceuticals Limited ₹9.25 L |
Pharmaceuticals & Biotechnology | 0.45% | 0.60% | +0.15% |
| 8 | Ajanta Pharma Limited ₹18.79 L |
Pharmaceuticals & Biotechnology | 1.08% | 1.22% | +0.14% |
| 9 | Sai Life Sciences Limited ₹24.01 L |
Pharmaceuticals & Biotechnology | 1.43% | 1.56% | +0.13% |
| 10 | Anthem Biosciences Limited ₹10.55 L |
Pharmaceuticals & Biotechnology | 0.56% | 0.69% | +0.13% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Max Healthcare Institute Limited ₹78.84 L |
Healthcare Services | 5.50% | 5.13% | -0.37% |
| 2 | Fortis Healthcare Limited ₹45.71 L |
Healthcare Services | 3.35% | 2.98% | -0.37% |
| 3 | Apollo Hospitals Enterprise Limited ₹95.78 L |
Healthcare Services | 6.50% | 6.24% | -0.26% |
| 4 | Biocon Limited ₹29.40 L |
Pharmaceuticals & Biotechnology | 2.08% | 1.91% | -0.17% |
| 5 | Lupin Limited ₹56.18 L |
Pharmaceuticals & Biotechnology | 3.77% | 3.66% | -0.11% |
| 6 | Aster DM Healthcare Limited ₹21.23 L |
Healthcare Services | 1.43% | 1.38% | -0.05% |
| 7 | Glenmark Pharmaceuticals Limited ₹40.06 L |
Pharmaceuticals & Biotechnology | 2.65% | 2.61% | -0.04% |
| 8 | Neuland Laboratories Limited ₹20.92 L |
Pharmaceuticals & Biotechnology | 1.40% | 1.36% | -0.04% |
| 9 | GlaxoSmithKline Pharmaceuticals Limited ₹13.04 L |
Pharmaceuticals & Biotechnology | 0.89% | 0.85% | -0.04% |
| 10 | Torrent Pharmaceuticals Limited ₹80.45 L |
Pharmaceuticals & Biotechnology | 5.27% | 5.24% | -0.03% |
44 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹1.56 Cr |
Pharmaceuticals & Biotechnology |
10.13%
|
|
| 2 |
₹1.35 Cr |
Pharmaceuticals & Biotechnology |
8.76%
|
|
| 3 |
₹95.78 L |
Healthcare Services |
6.24%
|
|
| 4 |
₹87.85 L |
Pharmaceuticals & Biotechnology |
5.72%
|
|
| 5 |
₹86.31 L |
Pharmaceuticals & Biotechnology |
5.62%
|
|
| 6 |
₹85.68 L |
Pharmaceuticals & Biotechnology |
5.58%
|
|
| 7 |
₹80.45 L |
Pharmaceuticals & Biotechnology |
5.24%
|
|
| 8 |
₹78.84 L |
Healthcare Services |
5.13%
|
|
| 9 |
₹56.18 L |
Pharmaceuticals & Biotechnology |
3.66%
|
|
| 10 |
₹52.63 L |
Pharmaceuticals & Biotechnology |
3.43%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.